Here are what the editors at HealthDay consider to be the most important developments in Pain Management for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Persistent Back Pain Linked to Earlier Mortality in Older Women
THURSDAY, Nov. 29, 2018 (HealthDay News) — Frequent persistent back pain is associated with increased mortality in older women, according to a study recently published in the Journal of General Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
FDA to Update Medical Device Approvals Process
TUESDAY, Nov. 27, 2018 (HealthDay News) — A major update of the United States’ system for approving medical devices was announced yesterday by the Food and Drug Administration.
CBS/AP News Article
More Information
Four Principles Underlie Patient and Family Partnership in Care
TUESDAY, Nov. 27, 2018 (HealthDay News) — Patient and family partnership in care should include treatment of patients and families with dignity and respect, their active engagement in all aspects of care, and their contribution to the improvement of health care systems and education of health care professionals, according to a position paper published online Nov. 27 in the Annals of Internal Medicine.
Position Paper
Editorial (subscription or payment may be required)
Pregnancy-Associated Mortality Involving Opioids Up
TUESDAY, Nov. 27, 2018 (HealthDay News) — From 2007 to 2016, there was a sharp increase in pregnancy-associated mortality involving opioids, according to a research letter recently published in the American Journal of Obstetrics & Gynecology.
ACA Coverage Substantial, but Did Not Impact Labor Markets
MONDAY, Nov. 26, 2018 (HealthDay News) — Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets, according to a report published by the Robert Wood Johnson Foundation and the Urban Institute.
Report: How Have Workers Fared Under the ACA?
FDA Warns Two Companies About Bogus Opioid Addiction Treatment
WEDNESDAY, Nov. 21, 2018 (HealthDay News) — Warning letters about products illegally marketed as treatments for opioid addiction, pain, and anxiety have been sent to two companies, the U.S. Food and Drug Administration said Tuesday.
Pain Management Telementoring May Cut Opioid Prescribing
TUESDAY, Nov. 20, 2018 (HealthDay News) — Military patients whose primary care clinicians participated in a telementoring program, including education on pain management best practices, have larger declines in opioid-related prescriptions than patients whose clinicians did not participate, according to a study published online Oct. 31 in the Journal of General Internal Medicine.
Opioid Misuse Varies With Sexual Orientation
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users 
CDC: Buprenorphine Treatment Differs in Urban, Rural Areas 
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus 
Botox Helpful in Alleviating Chronic Migraine in Pediatric Patients 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Updated Recommendations Address Medications to Prevent Migraine in Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens 
.jpg)